ASX - By Stock
|
PAA |
Re:
Ann: Following Extension of Survival, PAA Prepares Phase 3 Trial
|
|
PickEm
|
68 |
15K |
10 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
68
|
15K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Following Extension of Survival, PAA Prepares Phase 3 Trial
|
|
PickEm
|
68 |
15K |
22 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
68
|
15K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Phase IIb Dog Trial Achieves Interim Clinical Endpoints
|
|
PickEm
|
132 |
31K |
20 |
28/06/21 |
28/06/21 |
ASX - By Stock
|
132
|
31K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Top 50 Shareholders
|
|
PickEm
|
29 |
6.8K |
11 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
29
|
6.8K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust receives ethics approval for Phase I trial in MND
|
|
PickEm
|
67 |
15K |
12 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
67
|
15K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Onward and Upward , MPL vs Covid Trial Results Pending .....
|
|
PickEm
|
114 |
23K |
14 |
31/05/21 |
31/05/21 |
ASX - By Stock
|
114
|
23K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
PPL-1 and results with my dog
|
|
PickEm
|
189 |
41K |
4 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
189
|
41K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
New Media Attachment
|
|
PickEm
|
4 |
1.8K |
3 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
4
|
1.8K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
Company Maker?
|
|
PickEm
|
11 |
3.8K |
10 |
17/04/21 |
17/04/21 |
ASX - By Stock
|
11
|
3.8K
|
10
|
|
ASX - By Stock
|
AAM |
Re:
Ann: Unlocking Future Exploration Success at Cape Ray Gold Projct
|
|
PickEm
|
14 |
3.4K |
6 |
15/04/21 |
15/04/21 |
ASX - By Stock
|
14
|
3.4K
|
6
|
|
ASX - By Stock
|
AAM |
Re:
Ann: Unlocking Future Exploration Success at Cape Ray Gold Projct
|
|
PickEm
|
14 |
3.4K |
5 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
14
|
3.4K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
MY INPUT REGARDING PAA AND SARS-COV-2.
|
|
PickEm
|
41 |
9.3K |
5 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
41
|
9.3K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
MY INPUT REGARDING PAA AND SARS-COV-2.
|
|
PickEm
|
41 |
9.3K |
11 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
41
|
9.3K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
MY INPUT REGARDING PAA AND SARS-COV-2.
|
|
PickEm
|
41 |
9.3K |
14 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
41
|
9.3K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
PickEm
|
732 |
145K |
16 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
732
|
145K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
PickEm
|
732 |
145K |
21 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
732
|
145K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
PPL-1 and results with my dog
|
|
PickEm
|
189 |
41K |
12 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
189
|
41K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
PPL-1 and results with my dog
|
|
PickEm
|
189 |
41K |
8 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
189
|
41K
|
8
|
|
ASX - By Stock
|
RVR |
Re:
Antimony
|
|
PickEm
|
386 |
120K |
10 |
21/03/21 |
21/03/21 |
ASX - By Stock
|
386
|
120K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Imminent
|
|
PickEm
|
31 |
6.9K |
18 |
19/03/21 |
19/03/21 |
ASX - By Stock
|
31
|
6.9K
|
18
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
PickEm
|
1.4K |
315K |
7 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
1.4K
|
315K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
PickEm
|
1.4K |
315K |
10 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
1.4K
|
315K
|
10
|
|
ASX - By Stock
|
RVR |
Re:
Ann: RVR survey targets copper-rich mineralisation at Thalanga
|
|
PickEm
|
80 |
20K |
7 |
14/03/21 |
14/03/21 |
ASX - By Stock
|
80
|
20K
|
7
|
|
ASX - By Stock
|
RVR |
Re:
Antimony
|
|
PickEm
|
386 |
120K |
6 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
386
|
120K
|
6
|
|
ASX - By Stock
|
RVR |
Re:
Antimony
|
|
PickEm
|
386 |
120K |
2 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
386
|
120K
|
2
|
|
ASX - By Stock
|
RVR |
Re:
Antimony
|
|
PickEm
|
386 |
120K |
6 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
386
|
120K
|
6
|
|
ASX - By Stock
|
NOX |
Re:
Ann: NOXCOVID Trial Advances to Final Stage
|
|
PickEm
|
7 |
3.6K |
4 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
7
|
3.6K
|
4
|
|
ASX - By Stock
|
RVR |
Re:
Ann: Half Year Report - 31 December 2020
|
|
PickEm
|
117 |
28K |
11 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
117
|
28K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Can Monepantel help cure HIV ?
|
|
PickEm
|
23 |
5.7K |
11 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
23
|
5.7K
|
11
|
|
ASX - By Stock
|
RVR |
Re:
Yes
|
|
PickEm
|
84 |
20K |
5 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
84
|
20K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Can Monepantel help cure HIV ?
|
|
PickEm
|
23 |
5.7K |
8 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
23
|
5.7K
|
8
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Updated Corporate Presentation February-March 2021
|
|
PickEm
|
3 |
1.4K |
8 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
3
|
1.4K
|
8
|
|
ASX - By Stock
|
RVR |
Re:
Yes
|
|
PickEm
|
84 |
20K |
3 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
84
|
20K
|
3
|
|
ASX - By Stock
|
RVR |
Re:
Yes
|
|
PickEm
|
84 |
20K |
2 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
84
|
20K
|
2
|
|
ASX - By Stock
|
RVR |
Re:
Yes
|
|
PickEm
|
84 |
20K |
3 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
84
|
20K
|
3
|
|
ASX - By Stock
|
RVR |
Yes
|
|
PickEm
|
84 |
20K |
48 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
84
|
20K
|
48
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
PickEm
|
1.4K |
315K |
14 |
19/02/21 |
19/02/21 |
ASX - By Stock
|
1.4K
|
315K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
PickEm
|
1.4K |
315K |
8 |
19/02/21 |
19/02/21 |
ASX - By Stock
|
1.4K
|
315K
|
8
|
|
ASX - By Stock
|
NOX |
Re:
Ann: LuPIN Survival Outcome Confirmed by Conference Presentation
|
|
PickEm
|
25 |
7.4K |
6 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
25
|
7.4K
|
6
|
|
ASX - By Stock
|
NOX |
Re:
Ann: LuPIN Survival Outcome Confirmed by Conference Presentation
|
|
PickEm
|
25 |
7.4K |
15 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
25
|
7.4K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Update on Phase IIb Clinical Trial recruitment
|
|
PickEm
|
20 |
6.5K |
23 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
20
|
6.5K
|
23
|
|
ASX - By Stock
|
NOX |
Re:
Ann: LuPIN Survival Outcome Confirmed by Conference Presentation
|
|
PickEm
|
25 |
7.4K |
15 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
25
|
7.4K
|
15
|
|
ASX - By Stock
|
NOX |
Re:
Ann: LuPIN Survival Outcome Confirmed by Conference Presentation
|
|
PickEm
|
25 |
7.4K |
19 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
25
|
7.4K
|
19
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
PickEm
|
1.4K |
315K |
12 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.4K
|
315K
|
12
|
|
ASX - By Stock
|
HRZ |
Re:
Ann: Horizon To Retain And Advance Nimbus Silver-Zinc Project
|
|
PickEm
|
27 |
7.5K |
8 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
27
|
7.5K
|
8
|
|
ASX - By Stock
|
NOX |
Re:
GK clarifies IP situation
|
|
PickEm
|
4 |
1.7K |
12 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
4
|
1.7K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Covi-Pantel . NZ Trader Release
|
|
PickEm
|
1.4K |
315K |
13 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
1.4K
|
315K
|
13
|
|
ASX - By Stock
|
NOX |
Re:
Lupin results: Final cohort ( highest dose)
|
|
PickEm
|
2 |
1.2K |
9 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
2
|
1.2K
|
9
|
|
ASX - By Stock
|
NOX |
Re:
Chart
|
|
PickEm
|
15 |
6.0K |
2 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
15
|
6.0K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Major Survival Benefit in Prostate Cancer Patients Announced
|
|
PickEm
|
35 |
9.5K |
3 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
35
|
9.5K
|
3
|
|